WPRIM Management System> DCMS> Chinese Journal of Endocrinology and Metabolism> 2011> 27> 6

Volume: 27 Issue: 6

1. Individualized thyrotropin suppression in patients with differentiated thyroid cancers Page:451—453
2. Biological feature of radioiodine-131 and use of potassium iodide in nuclear accident Page:454—457
3. The reference range of serum thyrotropin in iodine-sufficient areas: An epidemiological study Page:458—462
4. Recombinant human thyrotropin-aided radioiodine treatment of differentiated thyroid carcinoma Page:463—466
5. Relationship betweenserum TSH and dyslipidemia Page:467—470
6. Observation of serum oxidative and antioxidative indices in patients with Graves′ disease Page:495—497
7. Effects of metformin on thyrotropin: A preliminary study Page:471—473
8. Beneficial effects of intensive therapy on arterial intima-media thickness and its risk factors in type 2 diabetic patients Page:474—477
9. Association of TSHR gene intron 1 polymorphisms with Graves′ disease Page:478—481
10. Efficacy of maggot debridement therapy in the treatment of diabetic foot ulcers Page:482—484
11. Immunological characteristics and pancreatic β-cell function in first-degree relatives of type 1 diabetes mellitus Page:485—488
12. Genetic analysis of neonatal diabetes mellitus and its influence on treatment outcome Page:488—491
13. Epidemiologic study on thyroid nodules in community population of Jiangsu Page:492—494
14. Genetic diagnosis and weight loss surgery of a case of Prader-Willi syndrome Page:498—501
15. Comparison of several early drug interventions in postmenopausal women with osteopenia Page:502—504
16. Gender difference in the establishment of animal model of Graves′ disease Page:505—508
17. Influence of the expression of parathyroid hormone 1 receptor to INS-1 cell function under high glucose condition Page:509—512
18. Effect of metformin on osteogenic and adipogenic differentiation of rat mesenchymal stem cells Page:513—517
19. Effect of RNAi targetingp38MAPK on high glucose-induced apoptosis of osteoblast MC3T3-E1 cell line Page:518—522
20. Utility of the BRAFT1799Amutation in papillary thyroid cancer Page:525—528
21. Update on the side effects of antithyroid drugs Page:529—532
22. Thyrotropin suppressive therapy in differentiated thyroid carcinoma Page:533—536
23. Progress in the studies on extra-islet effects of incretin Page:后插1—4

©2019 - Present World Health Organization Regional Office for the Western Pacific. All Rights Reserved.